| |
Scientific sessions organised and funded by GSK for healthcare professionals.
| | | | | Saturday 27 – Sunday 28 April | | | Join our GSK-sponsored scientific symposia on UTIs with infectious disease experts | | | | | | | | | |
Dear ESCMID Global attendees,
This year at the ESCMID Global Congress in Fira Gran Via, Barcelona, Spain, let’s get ahead of infectious diseases together. Come along with us to explore the disease burden and clinical landscape of UTIs with different specialists from across the multidisciplinary team at the following scientific symposia:
| | | | |
uUTI Across a Lifetime | |
Saturday 27 April
12:15–13:15 CEST
Location: Hall M
| |
ESCMID-appointed chair: Dr José Molina Gil‑Bermejo (Spain),
Danielle Powell (UK)
Faculty: Dr Annie Joseph (UK),
Dr Jennifer Kranz (Germany),
Dr Pamela Kushner (US)
| | | | | | | | | | |
Why does it have to be so complicated? Patient cases in cUTI | |
Sunday 28 April
16:00–17:30 CEST
Location: Hall M
| |
Chairs: ESCMID-appointed chair: Dr Gerard Lina (France),
Dr Aruni Mulgirigama (UK)
Faculty: Dr Juan Pablo Horcajada Gallego (Spain),
Prof. Keith Kaye (US),
Dr Erin McCreary (US),
Prof. Bhaskar Somani (UK)
| | | | | | | | | |
For more information on GSK Infectious Diseases at ESCMID, please click here.
We look forward to welcoming you to these GSK-sponsored scientific symposia at ESCMID Global 2024.
| | | | |
Please do not forward.
|
Scientific dissemination is based on published and accessible data and has an informative/educational purpose. To this end, the data is presented faithfully reflecting scientific publications without any modification or addition. Its content is protected by copyright and may not be reproduced (photo, recording or 'screen prints'), nor disclosed or transmitted to any third party by any means, without the written authorization of GSK.
La divulgación científica está basada en datos publicados y accesibles y tiene una finalidad informativa/formativa. A tal efecto, los datos se presentan reflejando fielmente las publicaciones científicas sin ninguna modificación o añadido. Su contenido está protegido por derechos de autor y no puede ser reproducido (foto, grabación o 'impresiones de pantalla’), ni divulgado ni transmitido a ningún tercero por cualquier medio, sin la autorización escrita de GSK.
NX‑GBL‑GPT‑EML‑240002 | April 2024
|
You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.
| | | | | | |